← Back to Vaccine Database

IMP CoVac-1 (SARS-CoV-2 HLA-DR peptides)

Protein based vaccine · VDDBV0419

Target & Classification

SARS-CoV-2SARS-CoV-2
Protein based vaccine
COVID-19
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT04546841 Phase 1COVID-19
NCT04954469 Phase 2COVID-19